reason report
bottom line maintain strong convict op-rat
rais pt repres price-to-earnings
revis ep quarter solid revenu
ep beat medic cost trend remain well control
importantli tax reform adjust ep guidanc revis
new rang materi
posit catalyst anticip see tax tailwind
recent legisl drive growth across manag even
particularli highest qualiti growth name new height
portion benefit fall margin also acceler privat
largest government-fund program medicar medicaid
optum growth remain strong top line margin expans
across segment fuel virtuou growth cycl partnership
unit healthcar see challeng competitor catch
cash flow gener juggernaut cfo
drive growth organ strateg
build empir across optum unit healthcar
domest oversea
solid ep top-lin beat consolid
miss modestli defer tax account sever
flu off-set larg favor prior period develop optum grew
top line impress expand margin across segment
medic cost trend came exhibit
ep guidanc revis impress new
rang make posit catalyst
hope anticip increas consolid guidanc
bp bp entir mechan
account half mm reduct premium
revenu gross-up insur fee lower tax rate
remaind rebat account medic cost trend guidanc
remain unchang i-day /- bp exhibit
ep growth continu newli
increas baselin outlook disposit tax
tailwind offer ep growth guidanc expect
continu rais ep dmg
abco banmedica meaning accret exhibit
base price-to-earnings
ep
net debt total capit
price-to-earnings lt ep growth
estimate lt ep growth compound-annual-growth-rate
compani inform leerink partner llc research
revenu billion ep dilut show ep exclud non-cash amort year quarterli
number may sum full-year number due round
pleas refer page analyst certif import disclosur price chart disclosur specif
cover compani statement valuat risk avail
investor view need connect dot favor
tax polici health polici re-acceler privat
medicar medicar advantag fuel growth
manag medicaid legisl health insur provid
moratorium upcom spend bill fuel
see accret irrevers growth benefit
particular leader busi fact potenti viabl
increment growth mm american senior like
irrevers privat program even presidenti
elect juici addit oper profit pool exhibit
tax reform tailwind enhanc alreadi virtuou cycl
growth optum unit healthcar optum continu
help industry-lead market share gain across uhc busi
segment medicaid dual employer-sponsor insur
individu leav competitor significantli behind view
optum turbo-charg engin view top-lin growth
margin expans across segment organ build-
 optum rx enjoy retent optum insight see
solid growth margin expans optum build-out top
cash flow juggernaut cfo pois
fuel across five strateg busi pillar
healthcar deliveri optum recent dmg sca
global recent banmedica digit healthcar recent
abco becom acquir choic win bid
recent covet medic group asset across state
 physician mm patient exhibit
valuat still leav much room upsid compound
growth multipl expans view rais pt
see rate feb report
guidanc nov continu accret deal activ posit
maintain strong convict op-rat rais pt
repres price-to-earnings revis ep quarter solid
revenu ep beat medic cost trend remain well control importantli tax
reform adjust guidanc revis new rang
materi posit catalyst anticip see tax tailwind recent
legisl drive growth across manag even particularli highest qualiti
growth name new height portion benefit fall margin also acceler
privat largest government-fund program medicar medicaid optum
growth remain strong top line margin expans across segment fuel
virtuou growth cycl partnership unit healthcar see challeng
competitor catch cash flow gener juggernaut cfo
drive growth organ strateg build empir
across optum unit healthcar domest oversea
consolid miss modestli defer tax account
sever flu off-set larg favor prior period develop optum grew top line
impress expand margin across segment medic cost trend came
report solid beat ep top-lin estim
unitedheatlhgroup earningsreport estimatesconsensu estimatesreport sequentialreport incom rx inc
defer tax account partial off-set prior year reserv develop
unitedheatlhgroup metricsreport estimatesconsensu estimatesreport sequenti bp report yoy bp metricsconsolid oper oper oper tax rate tax rate cost day cfo/net full year consolid medic care ratio percent increas basi point year-over-year basi point increas health insur tax deferr partial off-set million favor prior year reserv develop compar million fourth quarter consolid medic care ratio percent reflect consist medic cost trend press releas inc
compani report sequenti membership growth led growth medicaid commerci
unitedheatlhgroup membership estim consensu estim report chang sequentialreport servedcommerci fee-bas includ fee base medicar public medic part leerink consensu estim commerci risk-bas includ individu report estimatesconsensu estim beat/miss leerink report estimatesconsensu estim estimatesreport marginsearn mm revenu mm unitedhealth group inc
guidanc revis impress new rang
make posit catalyst hope anticip increas
consolid guidanc bp /- bp entir mechan
account half mm reduct premium revenu
gross-up insur fee lower tax rate remaind rebat account
medic cost trend guidanc remain unchang i-day /- bp
ep revis expect posit catalyst view
leerinkconsensusrevenu amort earn weighted-avg share net net ep excl amort flow oper paid repurchas expenditur guidanc investor updat guidanc unitedhealth group inc
guidanc revis bp mechan account
medic trend guidanc remain unchang i-day
outlook disposit tax tailwind offer ep
growth guidanc expect continu rais ep dmg
abco banmedica meaning accret
expect medic care ratio run rang plu minu basi point midpoint increas much basi point prior outlook driven sole mechan relat tax rate chang let get back clear million million compris two compon minimum rebat compon less half compon greater compon realli lower premium gross-up feder rate declin realli want clear term work minimum less half million million realli mechan impact recaptur impact lower premium gross-up major million million john offic ceo evp cfo inc call full year commerci medic cost trend continu forecast trend plu minu basi point steven nelson evp ceo-uhc inc call inc
expect ep growth continu rais ep
investor view need connect dot favor tax polici health
polici re-acceler privat medicar medicar advantag
fuel growth manag medicaid legisl health insur provid moratorium
upcom spend bill fuel see accret irrevers
growth benefit particular leader busi fact potenti
viabl increment growth mm american senior like irrevers
privat program even presidenti elect juici addit oper
profit pool
favor tax health polici re-acceler privat medicar potenti
hipf moratorium fuel addit accret growth
tax reform tailwind enhanc alreadi virtuou cycl growth optum
unit healthcar optum continu help industry-lead market share gain across
uhc busi segment medicaid dual employer-sponsor insur
individu leav competitor significantli behind view
tax reform tailwind enhanc virtuou cycl growth optum uhc help uhc
view optum turbo-charg engin top-lin growth margin expans
across segment organ build-out optum rx enjoy retent
optum insight see solid growth margin expans optum build-out top
optum continu strong top-lin growth
optum rx seen solid growth script
first foremost start strategi build optumcar high-valu ambulatori care sever year ago sever year strategi addit dmg anoth step forward process excit opportun combin dmg would also remind midst approv process underway step forward us allow us combin dmg outstand clinician local leadership nation leadership andrew hayek ceo optumhealth inc inc call one five key area growth futur one earli stage feel like assembl rel quickli one thing enter market anoth thing appli inform technolog realli enabl health system strong perform make differ cost qualiti consum receiv market come come year strategi continu roll david scott wichmann ceo director inc rx adj script mm inc
optum insight backlog grew nice strong contribut state gov busi
optum health showcas solid perform stead gain consum serv
cash flow juggernaut cfo pois fuel
across five strateg busi pillar healthcar deliveri optum recent
dmg sca pharmaci servic optum rx consum centric benefit global
recent banmedica digit healthcar recent abco becom
acquir choic win bid recent covet medic group asset
across state physician mm patient
strong continu fuel across strateg pillar
realli noth realli acceler pace acquisit coincident two acquisit happen come time indic line nice two five growth area busi long indic interest measur invest global banmdica allow us get three addit south american market studi market five year allow us advanc posit know open process right close transact one dmg acquisit would character coincident highli strateg term ambit interest build optumcar platform overal david scott wichmann ceo director inc call banmdica organ known long time studi market long time market leader across chile colombia peru healthcar benefit medic deliveri realli strong local manag team proven track record deliv consist high-margin growth across line busi across three countri similar brazil see opportun creat valu combin strong local team strong platform enterpris capabl across clinic technolog data analyt molli joseph ceo-unitedhealthcar global evp global inc call advisori board close think latter part novemb process kind implement optum playbook term integr align gone extrem well well receiv marketplac realli believ go enhanc sale pipelin well sale complementari busi manag team strong complementari us look lot good thing advisori board larri renfro offic ceo vc- ceo-optum inc call inc
compani continu build strateg portfolio within optum three acquisit
global remain prioriti recent acquisit banmedica expand unh presenc
latin america
optum launch nowclin optumizem optum financi servicesdign health optum launch optum launch optum institutecollabor tucson medic centerlaunch optum oneoptum rx acquir catamaranoptum acquir medexpress urgent clinicsoptum rx partner walgreensoptum partner quest affili acquisitionabco healthcar acquisitiondmg acquisit inc
debt cap remain give room strateg acquisit
valuat still leav much room upsid compound growth multipl
expans view rais pt see rate feb
report guidanc nov continu accret deal activ posit catalyst
trade price-to-earnings consensu ep estim
incom servic oper costsmed product oper incom incom earn growth net share dilut earn per ep ep chang growth sg ratio oper sg exclud includ invest incom unitedhealth group inc
care risk-bas advantag medicar public servic medic part prescript drug inc
primari valuat methodolog base rel price-to-earnings rel price-to-earnings
track function compani histori manag group averag assess
potenti price-to-earnings expans next month base forward forecast
contempl underli fundament implic healthcar reform dcf valuat
leverag forward forecast wacc termin growth rate inform
potenti multipl expans along sector compani specif catalyst expect
greater potenti multipl expans dcf valuat point significantli upsid
peer current trade level
free cash flow yield ratio also inform potenti multipl expans
except low ratio and/or high free cash flow yield point potenti greater
multipl expans use absolut rel price-to-earnings multipl base approach valuat
ep estim combin price-to-earnings base approach dcf model point
intrins valu compani plu add premium deal probabl
price target repres price-to-earnings ep pt reflect
higher probabl aet-cv deal closur
downsid risk invest thesi valuat aet legisl regulatori
polici chang could either dis-intermedi health insur us benefit
marketplac place unforeseen top-lin margin headwind commerci medicar
advantag medicaid dual elig book busi not-for-profit health insur
price irrat commerci health benefit marketplac acceler employ exit
sponsorship health benefit us marketplac post implement
afford act advers select public exchang protect adequ
given delay true-up govern payment acquisit asset
without attract return capit investor organiz and/or oper risk
lead execut mis-step downsid risk earn
upsid risk invest thesi valuat aet accret acquisit
use debt rais deal success appeal court decis
primari valuat methodolog base rel price-to-earnings rel price-to-earnings
track function compani histori manag group averag assess
potenti price-to-earnings expans next month base forward forecast
contempl underli fundament implic healthcar reform
dcf valuat leverag forward forecast wacc termin growth rate
inform potenti multipl expans along sector compani specif catalyst
expect greater potenti multipl expans dcf valuat point significantli
upsid peer current trade level free cash flow yield ratio also inform
potenti multipl expans except low ratio and/or high free cash flow yield
point potenti greater multipl expans
new pt contempl price-to-earnings base case ep
risk invest thesi valuat
legisl regulatori polici chang could either dis-intermedi
insur us benefit marketplac place unforeseen top-lin margin
headwind commerci medicar advantag medicaid dual elig book
not-for-profit health insur price irrat commerci health benefit
acceler employ exit sponsorship health benefit us
marketplac post implement afford act
advers select public exchang protect adequ given delay
true-up govern payment
acquisit asset without attract return capit investor
organiz and/or oper risk drive execut mis-step downsid risk
earn
primari valuat methodolog base rel price-to-earnings rel price-to-earnings
track function compani histori manag group averag assess
potenti price-to-earnings expans next month base forward forecast
contempl underli fundament implic healthcar reform dcf valuat
leverag forward forecast wacc termin growth rate inform
potenti multipl expans along sector compani specif catalyst expect
greater potenti multipl expans dcf valuat point significantli upsid
peer current trade level free cash flow yield ratio also inform
potenti multipl expans except low ratio and/or high free cash flow yield
point potenti greater multipl expans
base price-to-earnings multipl appli ep guidanc rate ci outperform
price target
non-profit bcb plan insur price irrat commerci market
medic cost trend come higher anticip potenti econom downturn
provid re-up intens servic deliveri cobra acceler uptak
member util care advanc layoff pandem
employ exit rapidli sponsorship health benefit combat medic
cost inflat catalyz econom downturn
risk declin invest yield invest impair
state-bas actuari rate review limit sound price underwrit caus
longer term state-bas insur exchang advers select reduc
sustain earn power employ dump employe health insur
exchang signific margin compress potenti downsid membership
top line also present long-term risk
polit shock lead singl payer
compani specif risk signific declin equiti market could result increas
fund compani pension oblig polit legal oper regulatori
econom risk foreign oper
dcf valuat leverag forward forecast wacc termin growth rate
inform potenti multipl expans along sector compani specif catalyst
expect greater potenti multipl expans dcf valuat point significantli
upsid peer current trade level free cash flow yield ratio also inform
potenti multipl expans except low ratio and/or high free cash flow yield
point potenti greater multipl expans price base case
pro forma ep estim post fide acquisit
risk valuat includ
start-up cost underwrit issu associ new busi on-board
particularli challeng new popul dual elig
annual off-cycl rate chang state medicaid program
uncertainti associ competit bid process state
legisl regulatori judici polici chang medicaid entitl program
state feder suprem court level also risk consid
remain posit reiter op rate month pt
contempl price-to-earnings ep
risk invest thesi valuat legisl regulatori
polici chang could either dis-intermedi health insur us benefit
marketplac place unforeseen top-lin margin headwind commerci medicar
advantag medicaid dual elig book busi not-for-profit health insur
price irrat commerci health benefit marketplac acceler employ exit
sponsorship health benefit us marketplac post implement
afford act advers select public exchang protect adequ
given delay true-up govern payment acquisit asset
without attract return capit investor organiz and/or oper risk
lead execut mis-step downsid risk earn acceler medic cost trend
util improv economi
pt reflect price-to-earnings ep
start-up cost underwrit issu associ new busi on-board
particularli challeng new popul dual elig
annual off-cycl rate chang state medicaid program
uncertainti associ competit bid process state
legisl regulatori judici polici chang medicaid
scale issu result loss specialti rx pharmaci contract
acquisit offer adequ return capit
upsid takeout substanti premium key risk
carve-out behavior health servic current state contract
primari valuat methodolog base rel price-to-earnings rel price-to-earnings
track function compani histori manag group averag assess
potenti price-to-earnings expans next month base forward forecast
contempl underli fundament implic healthcar reform
dcf valuat leverag forward forecast wacc termin growth rate
inform potenti multipl expans along sector compani specif catalyst
expect greater potenti multipl expans dcf valuat point significantli
upsid peer current trade level
free cash flow yield ratio also inform potenti multipl expans
except low ratio and/or high free cash flow yield point potenti greater
base post month turnaround rate outperform pt
contempl price-to-earnings ep
risk highlight first spike util on-board new state contract
dual elig integr second state-bas insur exchang result advers
select reduc sustain earn power third state-bas contract rate increas
suffici cover medic trend off-set industri fee medicaid premium fourth risk re-
procur exist contract could creat substanti downsid risk volatil fifth
legisl judici risk manag medicaid entitl extrem case singl
payer model also possibl downsid
primari valuat methodolog base rel price-to-earnings rel price-to-earnings
track function compani histori manag group averag assess
potenti price-to-earnings expans next month base forward forecast
contempl underli fundament implic healthcar reform
dcf valuat leverag forward forecast wacc termin growth rate
inform potenti multipl expans along sector compani specif catalyst
expect greater potenti multipl expans dcf valuat point significantli
upsid peer current trade level
free cash flow yield ratio also inform potenti multipl expans
except low ratio and/or high free cash flow yield point potenti greater
rate outperform price target contempl price-to-earnings
cash ep
non-profit bcb plan insur price irrat commerci market rapidli
medic cost trend come higher anticip potenti double-dip recess
provid re-up intens servic deliveri cobra acceler uptak member util
care advanc lay-off pandem
employ exit rapidli sponsorship health benefit combat medic cost
inflat catalyz double-dip recess
risk declin invest yield invest impair
state-bas actuari rate review limit sound price underwrit caus substanti
long-term state base health insur exchang advers select reduc
sustain earn power employ dump employe health insur
exchang signific margin compress also potenti downsid membership
risk relat collect industri fee medicar medicaid premium
polit shock lead singl payer
compani specif risk downsid risk price target includ acquisit asset
arena yield adequ return capit
primari valuat methodolog base rel price-to-earnings rel price-to-earnings
track function compani histori manag group averag assess
potenti price-to-earnings expans next month base forward forecast
contempl underli fundament implic healthcar reform
dcf valuat leverag forward forecast wacc termin growth rate
inform potenti multipl expans along sector compani specif catalyst
expect greater potenti multipl expans dcf valuat point significantli
upsid peer current trade level
free yield ratio also inform potenti multipl expans
except low ratio and/or high free yield point potenti greater
base rate wcg outperform pt contempl price-to-earnings
ep
downsid risk price target includ execut new state contract dual elig
award rate increas suffici cover medic trend off-set health insur fee
obamacar medicaid premium potenti dial medicaid expans ky
downsid risk medicar advantag reimburs obamacar headwind exacerb
wcg under-perform qualiti rate upsid risk price target includ
take-out larger player
